NYXH
Nyxoah S.A.
NYXH
Nyxoah S.A.
$ 1.6
-
1 of 5 dimensions have missing or inapplicable inputs and score 0. The total includes these dimensions.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The companyâs lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Asset | Price | Div. Yield |
|---|